A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants
PHASE1CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
December 27, 2023
Primary Completion Date
January 4, 2024
Study Completion Date
January 4, 2024
Conditions
Healthy Volunteers
Interventions
DRUG
Brensocatib
Brensocatib oral solutions will be expectorated following the tasting.
Trial Locations (1)
75247
USA001, Dallas
All Listed Sponsors
lead
Insmed Incorporated
INDUSTRY
NCT06178783 - A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants | Biotech Hunter | Biotech Hunter